UBS lowered the firm’s price target on Molina Healthcare (MOH) to $180 from $260 and keeps a Neutral rating on the shares. Higher cost trends are leading to an uncertain outlook, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH: